Kingskin Saca Callos

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the removal of corns and calluses. It provides relief from pain associated with these conditions by effectively removing the corns and calluses.

There are no known teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Healthcare professionals are advised to follow the outlined procedure for the application of the treatment to corns and calluses.

The affected area should be washed and dried thoroughly prior to application. A small amount of the product should be applied using an applicator, ensuring that each corn or callus is sufficiently covered. After application, the area should be allowed to dry completely.

This procedure may be repeated once or twice daily as needed, up to a maximum of 14 days, or until the corn or callus is removed. For enhanced efficacy, it is recommended to soak the corn or callus in warm water for approximately 5 minutes prior to application to assist in the removal process.

Contraindications

Use of this product is contraindicated in the following situations:

• Application on irritated skin or on any area that is infected or reddened, due to the potential for exacerbating the condition.

• In patients with diabetes, as there may be an increased risk of complications related to skin integrity and healing.

• In individuals with poor blood circulation, which may impair the delivery of the product and increase the risk of adverse effects.

Warnings and Precautions

The product is intended for external use only. It is important to note that the formulation is flammable; therefore, it must be kept away from fire or flame to prevent any hazardous incidents.

This product should not be applied to irritated skin, infected areas, or reddened skin. Additionally, individuals with diabetes or those who have poor blood circulation should refrain from using this product due to potential complications.

In the event that discomfort persists after application, it is advised to discontinue use and consult a healthcare professional, such as a doctor or podiatrist, for further evaluation and guidance.

In cases of accidental ingestion, immediate medical assistance is required. It is crucial to contact a Poison Control Center or seek emergency medical help without delay to ensure appropriate care is provided.

Side Effects

Patients should be aware of several important warnings and precautions associated with the use of this product. It is intended for external use only and is flammable; therefore, it should be kept away from fire or flame. The product should not be applied to irritated skin, infected or reddened areas, or used by individuals who are diabetic or have poor blood circulation.

During use, if the product comes into contact with the eyes, it is essential to flush the eyes with water for 15 minutes. Additionally, patients should avoid inhaling vapors from the product. If discomfort persists, it is advised to stop using the product and consult a doctor or podiatrist.

For pregnant or lactating individuals, consultation with a healthcare professional is recommended prior to use. It is crucial to keep this product out of reach of children. In the event of accidental ingestion, medical assistance should be sought immediately, or contact a Poison Control Center for guidance.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Kingskin Saca Callos (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, it is crucial to seek medical assistance or contact a Poison Control Center immediately.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Pregnant patients and those who are lactating should consult a healthcare professional before using this product. It is essential to evaluate the potential risks and benefits associated with the use of this medication during pregnancy and lactation. Healthcare providers should consider the individual circumstances of each patient, including any underlying health conditions and the potential impact on fetal outcomes.

Lactation

Lactating mothers are advised to consult a doctor prior to using this product. There is no specific data available regarding the excretion of this product in breast milk or its effects on breastfed infants. Therefore, healthcare professionals should consider the potential risks and benefits when recommending this product to lactating patients.

Renal Impairment

Patients with renal impairment have no specific information regarding dosage adjustments, special monitoring, or safety considerations provided in the drug insert. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the lack of data necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in these patients to ensure safety and efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of accidental ingestion, it is imperative to seek medical assistance or contact a Poison Control Center without delay. Prompt action is crucial to ensure the safety and well-being of the patient.

Healthcare professionals should be aware that symptoms of overdosage may vary depending on the substance involved. Therefore, a thorough assessment of the patient's condition is essential.

Management of overdosage should be guided by the specific clinical scenario and may include supportive care and symptomatic treatment. Continuous monitoring of the patient's vital signs and clinical status is recommended to address any complications that may arise.

In all cases of suspected overdosage, it is vital to gather as much information as possible regarding the substance, the amount ingested, and the time of ingestion to facilitate appropriate medical intervention.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's safety profile in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are provided in the insert.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center in the event of accidental ingestion of the product. It is important to inform patients that this product should not be applied to irritated skin, infected or reddened areas, or used by individuals who are diabetic or have poor blood circulation.

Patients should be instructed to discontinue use and consult a doctor or podiatrist if discomfort persists after application. Additionally, healthcare providers should emphasize the importance of avoiding contact with the eyes; if the product does get into the eyes, patients should flush with water for 15 minutes. Lastly, patients should be cautioned against inhaling vapors while using this product to ensure their safety and well-being.

Storage and Handling

The product is supplied in a tightly capped bottle. It should be stored at room temperature, away from heat sources, to maintain its integrity. It is essential to ensure that the seal over the cap is intact; the product should not be used if the seal is torn or missing.

Additional Clinical Information

The medication is administered topically, with the recommended frequency being once or twice daily as needed, up to a maximum duration of 14 days, or until the corn or callus is removed. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Kingskin Saca Callos, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)